CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans
- 31 March 2000
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 18 (18), 1920-1924
- https://doi.org/10.1016/s0264-410x(99)00443-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Complete Sequencing of a Gibbon Hepatitis B Virus Genome Reveals a Unique Genotype Distantly Related to the Chimpanzee Hepatitis B VirusVirology, 1996
- Influence of smoking on immunological responses to hepatitis B vaccineVaccine, 1994
- Randomised placebo-controlled trial of recombinant interleukin-2 in chronic uraemic patients who are non-responders to hepatitis B vaccineThe Lancet, 1994
- Overcoming class II-linked non-responsiveness to hepatitis B vaccineVaccine, 1994
- The immune response to hepatitis B vaccine in humans: inheritance patterns in families.The Journal of Experimental Medicine, 1992
- Genetic Prediction of Nonresponse to Hepatitis B VaccineNew England Journal of Medicine, 1989
- Anti-HBs Responses to Vaccination with a Human Hepatitis B Vaccine Made by Recombinant DNA Technology in YeastThe Journal of Infectious Diseases, 1986
- CLINICAL EVALUATION OF A RECOMBINANT HEPATITIS B VACCINEThe Lancet, 1984
- Development and Chimpanzee Testing of a Vaccine against Human Hepatitis BExperimental Biology and Medicine, 1976
- Hepatitis-Associated Antigen in ChimpanzeesThe Journal of Infectious Diseases, 1971